637 related articles for article (PubMed ID: 26085051)
21. Statistical design for formulation optimization of hydrocortisone butyrate-loaded PLGA nanoparticles.
Yang X; Patel S; Sheng Y; Pal D; Mitra AK
AAPS PharmSciTech; 2014 Jun; 15(3):569-87. PubMed ID: 24504495
[TBL] [Abstract][Full Text] [Related]
22. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
[TBL] [Abstract][Full Text] [Related]
23. Novel nanoparticulate gel formulations of steroids for the treatment of macular edema.
Boddu SH; Jwala J; Vaishya R; Earla R; Karla PK; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2010 Feb; 26(1):37-48. PubMed ID: 20148659
[TBL] [Abstract][Full Text] [Related]
24. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
25. PLGA microparticle-embedded thermosensitive hydrogels for sustained release of hydrophobic drugs.
Joung YK; Choi JH; Park KM; Park KD
Biomed Mater; 2007 Dec; 2(4):269-73. PubMed ID: 18458485
[TBL] [Abstract][Full Text] [Related]
26. In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides.
Chen YS; Alany RG; Young SA; Green CR; Rupenthal ID
Drug Deliv; 2011; 18(7):493-501. PubMed ID: 21696294
[TBL] [Abstract][Full Text] [Related]
27. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
Giovino C; Ayensu I; Tetteh J; Boateng JS
Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
[TBL] [Abstract][Full Text] [Related]
28. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
29. In-situ forming gels containing fluorometholone-loaded polymeric nanoparticles for ocular inflammatory conditions.
Gonzalez-Pizarro R; Carvajal-Vidal P; Halbault Bellowa L; Calpena AC; Espina M; García ML
Colloids Surf B Biointerfaces; 2019 Mar; 175():365-374. PubMed ID: 30554015
[TBL] [Abstract][Full Text] [Related]
30. A sustained release formulation of chitosan modified PLCL:poloxamer blend nanoparticles loaded with optical agent for animal imaging.
Ranjan AP; Zeglam K; Mukerjee A; Thamake S; Vishwanatha JK
Nanotechnology; 2011 Jul; 22(29):295104. PubMed ID: 21693801
[TBL] [Abstract][Full Text] [Related]
31. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
32. Hydrocortisone loaded poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for topical ophthalmic administration: Preparation, characterization and evaluation of ophthalmic toxicity.
Álvarez-Álvarez L; Barral L; Bouza R; Farrag Y; Otero-Espinar F; Feijóo-Bandín S; Lago F
Int J Pharm; 2019 Sep; 568():118519. PubMed ID: 31310791
[TBL] [Abstract][Full Text] [Related]
33. Release of a wound-healing agent from PLGA microspheres in a thermosensitive gel.
Machado HA; Abercrombie JJ; You T; Deluca PP; Leung KP
Biomed Res Int; 2013; 2013():387863. PubMed ID: 24224161
[TBL] [Abstract][Full Text] [Related]
34. Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan-thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers.
Şenyiğit ZA; Karavana SY; İlem-Özdemir D; Çalışkan Ç; Waldner C; Şen S; Bernkop-Schnürch A; Baloğlu E
Int J Nanomedicine; 2015; 10():6493-507. PubMed ID: 26508855
[TBL] [Abstract][Full Text] [Related]
35. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ
Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438
[TBL] [Abstract][Full Text] [Related]
36. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.
Gupta H; Jain S; Mathur R; Mishra P; Mishra AK; Velpandian T
Drug Deliv; 2007 Nov; 14(8):507-15. PubMed ID: 18027180
[TBL] [Abstract][Full Text] [Related]
37. Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits.
Fouda NH; Abdelrehim RT; Hegazy DA; Habib BA
Drug Deliv; 2018 Nov; 25(1):1340-1349. PubMed ID: 29869516
[TBL] [Abstract][Full Text] [Related]
38. Prolonged injectable formulation of Nafarelin using in situ gel combination delivery system.
Alizadeh B; Bahari Javan N; Akbari Javar H; Khoshayand MR; Dorkoosh F
Pharm Dev Technol; 2018 Feb; 23(2):132-144. PubMed ID: 28430010
[TBL] [Abstract][Full Text] [Related]
39. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
Fu T; Yi J; Lv S; Zhang B
J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
[TBL] [Abstract][Full Text] [Related]
40. Local drug delivery using poly(lactic-co-glycolic acid) nanoparticles in thermosensitive gels for inner ear disease treatment.
Kim DH; Nguyen TN; Han YM; Tran P; Rho J; Lee JY; Son HY; Park JS
Drug Deliv; 2021 Dec; 28(1):2268-2277. PubMed ID: 34668836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
